Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics

Cancer Research

Volumn 73, Issue 16, 2013, Pages 4992-5002

  Huang, Qiang ^a   Tan, Yexiong ^b   Yin, Peiyuan ^a   Ye, Guozhu ^a   Gao, Peng ^a   Lu, Xin ^a   Wang, Hongyang ^b   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETAINE; DESATURASE; GLUTATHIONE; OXYGENASE; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; PROPIONYLCARNITINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FATTY ACID OXIDATION; FEMALE; GLUCONEOGENESIS; GLYCOLYSIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOME; METABOLOMICS; PRIORITY JOURNAL;

EID: 84882632229     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0308     Document Type: Article

References (38)

1. Pineau P, Tiollais P. Hepatitis B vaccination: a major player in the control of primary liver cancer. Pathol Biol (Paris) 2010;58:444-53.
2. West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006;94:1751-8.
3. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008;452:230-3.
4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
5. Lazebnik Y. What are the hallmarks of cancer? Nat Rev Cancer 2010;10:232-3.
6. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181-9.
7. Yin PY, Wan DF, Zhao CX, Chen J, Zhao XJ, Wang WZ, et al. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol Biosyst 2009;5:868-76.
8. Shariff MI, Gomaa AI, Cox IJ, Patel M, Williams HR, Crossey MM, et al. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. J Proteome Res 2011;10:1828-36.
9. Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, et al. Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatol 2011;55:896-905.
10. Griffin JL, Nicholls AW. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 2006;7:1095-107.
11. Yang YX, Li CL, Nie X, Feng XS, Chen WX, Yue Y, et al. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning H-1 NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res 2007;6:2605-14.
12. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009;457:910-4.
13. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 2009;69:4918-25.
14. Tan YX, Yin PY, Tang L, Xing WB, Huang Q, Cao D, et al. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis. Mol Cell Proteomics 2012;11:M111 010694.
15. Chen J, Zhang XY, Cao R, Lu X, Zhao SM, Fekete A, et al. Serum 27- nor-5 beta-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J Proteome Res 2011;10:2625-32.
16. Yin PY, Zhao XJ, Li QR, Wang JS, Li JS, Xu GW. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res 2006;5:2135-43.
17. Smilde AK, van der Werf MJ, Bijlsma S, van der Werff-van-der Vat BJC, Jellema RH. Fusion of mass spectrometry-based metabolomics data. Anal Chem 2005;77:6729-36.
18. Huang Q, Yin PY, Wang J, Chen J, Kong HW, Lu X, et al. Method for liver tissue metabolic profiling study and its application in type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry. J Chromatogr B 2011;879:961-7.
19. Chen J, Wang WZ, Lv S, Yin PY, Zhao XJ, Lu X, et al. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal Chim Acta 2009;650:3-9.
20. Chen J, Zhao Xj, Fritsche J, Yin PY, Schmitt-Kopplin P, Wang WZ, et al. Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal Chem 2008;80:1280-9.
21. Go EP. Database resources in metabolomics: an overview. J Neuroimmune Pharm 2010;5:18-30.
22. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism 2009;9:311-26.
23. Warburg O. On respiratory impairment in cancer cells. Science 1956;124:269-70.
24. Bi XZ, Lin QS, Foo TW, Joshi S, You T, Shen HM, et al. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics 2006;5: 1119-30.
25. Puskas LG, Feher LZ, Vizler C, Ayaydin F, Raso E, Molnar E, et al. Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis 2010;9:56.
26. Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012; 485:661-5.
27. DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010; 29:313-24.
28. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009;458: 762-5.
29. Wu GY, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-92.
30. Chaiswing L, Oberley TD. Extracellular/microenvironmental redox state. Antioxid Redox Signal 2010;13:449-65.
31. Csanaky IL, Aleksunes LM, Tanaka Y, Klaassen CD. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. Am J Physiol-gastr L 2009;297:G419-G33.
32. Li TG, Chiang JYL. Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res 2009;2009:501739.
33. Han C, Bowen WC, Li GY, Demetris AJ, Michalopoulos GK, Wu T. Cytosolic phospholipase A2alpha and peroxisome proliferator- activated receptor gamma signaling pathway counteracts transforming growth factor beta-mediated inhibition of primary and transformed hepatocyte growth. Hepatology 2010; 52:644-55.
34. Taketo MM, Sonoshita M. Phospolipase A2 and apoptosis. Biochim Biophys Acta 2002;1585:72-6.
35. Fong MY, McDunn J, Kakar SS. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS ONE 2011;6:e19963.
36. Vogel KR, Arning E, Wasek BL, Bottiglieri T, Gibson KM. Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAH (ENU2) mice. J Inherit Metab Dis 2013;36:513-23.
37. Matthews DE. An overview of phenylalanine and tyrosine kinetics in humans. J Nutr 2007;137:1549S-55S; discussion 73S-75S.
38. Linder N, Martelin E, Lundin M, Louhimo J, Nordling S, Haglund C, et al. Xanthine oxidoreductase - Clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells. Eur J Cancer 2009;45:648-55.